Mizuho Maintains Outperform on Chemours, Lowers Price Target to $25
Mizuho analyst John Roberts maintains Chemours (NYSE: CC ) with a Outperform and lowers the price target from $30 to $25.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.